Posts tagged University College London
ViroCell Announces new Board appointments
ViroCell Announces new Board appointments

ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today announces the appointment of J. David Enloe, Jr. to its Board of Directors and Martin Pule, MD, PhD to its Scientific Advisory Board, both leaders in their respective fields.

Read More
In the NewsFlorence BuchananCDMO, ViroCell Board of Directors, Pharmiweb.com, UK CDMO, ViroCell, Recro Pharma, Board of Directors, Scientific Advisory Board, Dr. Martin Pule, J. David Enloe, John W. Hadden II, Farzin Farzaneh, gene therapy, cell therapy, CGT, viral vector, AAV vectors, lentivirus vectors, University College London
ViroCell Announces New Board Appointments
ViroCell Announces New Board Appointments

ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today announces the appointment of J. David Enloe, Jr. to its Board of Directors and Martin Pule, MD, PhD to its Scientific Advisory Board, both leaders in their respective fields.

Read More
In the NewsFlorence BuchananCDMO, ViroCell Board of Directors, Scientific Advisory Board, J. David Enloe, Martin Pule, Pharmtech Focus, ViroCell, Board of Directors, UK CDMO, gene therapy, cell therapy, CGT, Recro Pharma, Lonza, University College London, Autolus Therapeutics, AUTL, John W. Hadden II, Farzin Farzaneh, David Enloe, vector design, AAV vectors, lentivirus vectors